Biggest News Aggregation in the World
📰 Johnk Botson News

Johnk Botson News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Johnk Botson. Real-time updates on events, politics, business and more.

Horizon Therapeutics plc: Sustained Patient Response to KRYSTEXXA (pegloticase) Injection with Methotrexate Compared to KRYSTEXXA Alone Shown through Month 12 in MIRROR Randomized Controlled Trial

-- Month 12 results from MIRROR randomized controlled trial to be featured on Nov. 13, 11:45 a.m. EST during plenary session at the American College of Rheumatology Convergence 2022 -- -- Imaging
United States Amanda Phraner Clin Rheumatol Tina Ventura Johnk Botson Ada Kumar

Horizon Therapeutics plc: FDA Approves KRYSTEXXA (pegloticase) Injection Co-Administered With Methotrexate, Expanding the Labeling to Help More People with Uncontrolled Gout Achieve a Complete Response to Therapy

-- Approval based on MIRROR randomized controlled trial, which showed significant improvement and sustained patient response to KRYSTEXXA with methotrexate compared to KRYSTEXXA alone -- -- Trial
United States Amanda Phraner Clin Rheumatol Tina Ventura Johnk Botson Ray Gordon

FDA Approves KRYSTEXXA (pegloticase) Injection Co-Administered With Methotrexate, Expanding the Labeling to Help More People with Uncontrolled Gout Achieve a Complete Response to Therapy

08.07.2022 - Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) expanding the labeling to include KRYSTEXXA (pegloticase) injection ... Seite 1
United States Johnk Botson Alaska Rheumatology Alliance Orthopedic Physicians Horizon Therapeutics

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science